Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension
- Resource Type
- Article
- Source
- In
Biomedicine & Pharmacotherapy May 2024 174 - Subject
- Language
- ISSN
- 0753-3322